Inhibition of NO-induced β-cell death by novel NF-κB inhibitor (-)-DHMEQ via activation of Nrf2-ARE pathway

Biochemical and Biophysical Research Communications

Volumn 433, Issue 2, 2013, Pages 181-187

  Ogasawara, Akira ^a   Simizu, Siro ^a   Ito, Ayumi ^a   Kawai, Toshihide ^b   Saisho, Yoshifumi ^b   Takei, Izumi ^c   Umezawa, Kazuo ^d  

^a KEIO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO DENTAL COLLEGE   (Japan)

^d AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

( ) DHMEQ; Apoptosis; NF B; Nrf2; Cell

Indexed keywords

DEHYDROXYMETHYLEPOXYQUINOMICIN; NITRIC OXIDE; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84877668193     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.062     Document Type: Article

References (33)

1. Mathis D., Vence L., Benoist C. Beta-cell death during progression to diabetes. Nature 2001, 414:792-798.
2. Eizirik D.L., Mandrup-Poulsen T. A choice of death-the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 2001, 44:2115-2133.
3. Wu G. Nitric oxide synthesis and the effect of aminoguanidine and NG-monomethyl-l-arginine on the onset of diabetes in the spontaneously diabetic BB rat. Diabetes 1995, 44:360-364.
4. Kutlu B., Cardozo A.K., Darville M.I., Kruhøffer M., Magnusson N., Ørntoft T., et al. Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 2003, 52:2701-2719.
5. Bonizzi G., Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
6. Heimberg H., Heremans Y., Jobin C., Leemans R., Cardozo A.K., Darville M., et al. Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 2001, 50:2219-2224.
7. Giannoukakis N., Rudert W.A., Trucco M., Robbins P.D. Protection of human islets from the effects of interleukin-1β by adenoviral gene transfer of an IκB repressor. J. Biol. Chem. 2000, 275:36509-36513.
8. Baker M.S., Chen X., Cao X.C., Kaufman D.B. Expression of a dominant negative inhibitor of NF-κB protects MIN6 β-cells from cytokine-induced apoptosis. J. Surg. Res. 2001, 97:117-122.
9. Eldor R., Yeffet A., Baum K., Doviner V., Amar D., Ben-Neriah Y., et al. Conditional and specific NF-κB blockade protects pancreatic β cells from diabetogenic agents. Proc. Natl. Acad. Sci. USA 2006, 103:5072-5077.
10. Motohashi H., Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 2004, 10:549-557.
11. Tong K.I., Padmanabhan B., Kobayashi A., Shang C., Hirotsu Y., Yokoyama S., et al. Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol. Cell. Biol. 2007, 27:7511-7521.
12. Robertson R.P., Harmon J., Tran P.O., Tanaka Y., Takahashi H. Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 2003, 52:581-587.
13. Wakabayashi N., Slocum S.L., Skoko J.J., Shin S., Kensler T.W. When NRF2 talks, who's listening?. Antioxid. Redox Signal. 2010, 13:1649-1663.
14. Kumar A., Negi G., Sharma S.S. Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IκB phosphorylation inhibitor) in experimental diabetic neuropathy. Biochimie 2012, 94:1158-1165.
15. Matsumoto N., Ariga A., To-e S., Nakamura H., Agata N., Hirano S., et al. Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin C. Bioorg. Med. Chem. Lett. 2000, 10:865-869.
16. Yamamoto M., Horie R., Takeiri M., Kozawa I., Umezawa K. Inactivation of NF-κB components by covalent binding of (-)-dehydroxymethylepoxyquinomicin to specific cysteine residues. J. Med. Chem. 2008, 51:5780-5788.
17. West M.J., Lowe A.D., Karn J. Activation of human immunodeficiency virus transcription in T cells revisited: NF-κB p65 stimulates transcriptional elongation. J. Virol. 2001, 75:8524-8537.
18. Niitsu Y., Hakamata M., Goto Y., Higashi T., Shoji M., Sugai T., et al. Chemoenzymatic synthesis of (2R,3R,4R)-dehydroxymethylepoxyquinomicin (DHMEQ), a new activator of antioxidant transcription factor Nrf2. Org. Biomol. Chem. 2011, 9:4635-4641.
19. Tonnesen M.F., Grunnet L.G., Friberg J., Cardozo A.K., Billestrup N., Eizirik D.L., et al. Inhibition of nuclear factor-κB or Bax prevents endoplasmic reticulum stress- but not nitric oxide-mediated apoptosis in INS-1E cells. Endocrinology 2009, 150:4094-4103.
20. Oyadomari S., Takeda K., Takiguchi M., Gotoh T., Matsumoto M., Wada I., et al. Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. Proc. Natl. Acad. Sci. USA 2001, 98:10845-10850.
21. McCullough K.D., Martindale J.L., Klotz L.O., Aw T.Y., Holbrook N.J. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol. 2001, 21:1249-1259.
22. Haynes C.M., Titus E.A., Cooper A.A. Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol. Cell 2004, 15:767-776.
23. Song B., Scheuner D., Ron D., Pennathur S., Kaufman R.J. Chop deletion reduces oxidative stress, improves β cell function, and promotes cell survival in multiple mouse models of diabetes. J. Clin. Invest. 2008, 118:3378-3389.
24. Nakagawa S., Arai Y., Mazda O., Kishida T., Takahashi K.A., Sakao K., et al. N-acetylcysteine prevents nitric oxide-induced chondrocyte apoptosis and cartilage degeneration in an experimental model of osteoarthritis. J. Orthop. Res. 2010, 28:156-163.
25. Sanvicens N., Gómez-Vicente V., Masip I., Messeguer A., Cotter T.G. Oxidative stress-induced apoptosis in retinal photoreceptor cells is mediated by calpains and caspases and blocked by the oxygen radical scavenger CR-6. J. Biol. Chem. 2004, 279:39268-39278.
26. Buckley B.J., Marshall Z.M., Whorton A.R. Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium. Biochem. Biophys. Res. Commun. 2003, 307:973-979.
27. Dhakshinamoorthy S., Porter A.G. Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J. Biol. Chem. 2004, 279:20096-20107.
28. Kröncke K.D., Brenner H.H., Rodriguez M.L., Etzkorn K., Noack E.A., Kolb H., et al. Pancreatic islet cells are highly susceptible towards the cytotoxic effects of chemically generated nitric oxide. Biochim. Biophys. Acta 1993, 1182:221-229.
29. Fu J., Woods C.G., Yehuda-Shnaidman E., Zhang Q., Wong V., Collins S., et al. Low-level arsenic impairs glucose-stimulated insulin secretion in pancreatic β cells: involvement of cellular adaptive response to oxidative stress. Environ. Health Perspect. 2010, 118:864-870.
30. Chandiramani N., Wang X., Margeta M. Molecular basis for vulnerability to mitochondrial and oxidative stress in a neuroendocrine CRI-G1 cell line. PLoS One 2011, 6:e14485.
31. Liu G.-H., Qu J., Shen X. NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim. Biophys. Acta 2008, 1783:713-727.
32. Yu M., Li H., Liu Q., Liu F., Tang L., Li C., et al. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cell. Signal. 2011, 23:883-892.
33. Umezawa K. Possible role of peritoneal NF-κB in peripheral inflammation and cancer: lessons from the inhibitor DHMEQ. Biomed. Pharmacother. 2011, 65:252-259.